NICOLE JONES: Open Payments
NPI 1548536246 · DEPTFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 48 payments from 21 companies in 2025. Trend: 2023 $172 · 2024 $111 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $100 |
| Dexcom, Inc. | 2 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $94 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Amneal Pharmaceuticals LLC | 4 | $85 |
| Ascendis Pharma Endocrinology Inc | 4 | $75 |
| Tandem Diabetes Care, Inc. | 2 | $60 |
| Corcept Therapeutics | 3 | $59 |
| Madrigal Pharmaceuticals | 2 | $54 |
| Insulet Corporation | 2 | $50 |
Products named: Dexcom G6 Transmitter, Kerendia, RECORLEV, UNITHROID, Yorvipath, Rybelsus, t:slim X2 Insulin Pump with Control-IQ, Korlym.
Industry payments across NJ — which companies pay providers there.
